pCPA Archives
Please find below previous updates on the status of pan-Canadian Pharmaceutical Alliance drug negotiations.
2017
As of May 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of April 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of March 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of February 28
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of January 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
2016
As of December 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of November 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of October 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of September 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of August 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of July 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of June 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of May 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of April 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of March 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of February 29
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of January 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
2015
As of December 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of November 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of October 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of September 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of August 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of July 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of June 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of May 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of April 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of March 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of February 28
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of January 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
2014
As of December 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of November 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of October 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of September 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of August 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of July 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of June 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of May 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of April 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of April 1
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of February 28
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of January 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
Initiatives
-
Health Care Innovation Working Group
The Health Care Innovation Working Group (HCIWG) is currently led by Ontario Premier Kathleen Wynne and Yukon, and composed of provincial and territorial...
-
Fiscal Arrangements Working Group
The Fiscal Arrangements Working Group was established in January 2012. The principles underlying the work of the working group are: To find solutions that work...
-
Economic Productivity and Innovation Working Group
Newfoundland and Labrador Premier Dwight Ball, Ontario Premier Kathleen Wynne, Québec Premier Philippe Couillard, Prince Edward Island Premier Wade...
-
Canadian Energy Strategy
As owners of natural resources, provinces and territories have an essential role to play in developing Canada as a global leader in energy development,...
-
Internal Trade
Premiers are committed to maintaining a modern and competitive Canadian market. They recognize the role that more open internal trade can play in helping...
-
The Council of the Federation Literacy Award
The Council of the Federation Literacy Award recognizes outstanding achievement, innovative practice and excellence in literacy. Thirteen awards are...
